Lupin Digital Health releases results of its digital therapeutics study with ACS patients – ET HealthWorld
Chennai: Showing the efficacy of digital therapeutics (DTx) among patients with acute coronary syndrome (ACS) and post-percutaneous coronary interventions, Lupin Digital Health (LDH), a DTx platform, has released the results of a study in India. The one-year-long study was aimed at evaluating the efficacy of LDH’s digital therapeutics platform, Lyfe, on cardiovascular events, rehospitalisation, medication … Read more